Subscriber Content Preview | Request a free trialSearch  


For Teva, poison pills and regulatory worries won't stop the march on Mylan

The generics giant's offer is contingent on the target dropping its own offer for Perrigo, which right now will be a tough sell to its shareholders. Continue reading

Comcast faces limited options in appeasing regulators wary of another mega-media deal

Discussions begin over possible concessions to address concerns about Time Warner Cable acquisition. Continue reading

Holcim, Lafarge shop U.S. assets as Summit Materials signs up to $450M deal

The merger partners still need buyers for three terminals and two grinding operations to ease their $46 billion combination past the FTC. Continue reading

Antitrust protections no 'road map' for merger challenges, regulators say

Common fear that merger agreement covenants will tip off officials to competitive harms called unfounded. Continue reading

GE's $23 billion financial asset sale to Blackstone, Wells Fargo will help it exit Fed oversight

Deals could allow GE Capital to lose 'systemically important' category as early as 2016. Continue reading

FedEx agrees to buy Netherlands' TNT Express for $4.8B

The offer is 16% less than an abortive bid by rival UPS, which pulled its offer when faced with an EC antitrust veto. Continue reading

Novartis makes history and the biosimilar industry looks even more attractive

Pfizer, Teva and Actavis are potential consolidators, while Momenta, Coherus and Epirus lead the list of likely targets. Continue reading

Insurgents know no bounds when it comes to the FTC

Antitrust hurdles? What antitrust hurdles? Activists often don't see any real regulatory problems. Continue reading

Supremacy's claws: How two judges are changing the pension debate

The Detroit and Stockton cases offer hope to cash-strapped cities and deal retirees a major setback. Continue reading

Four banks to watch while everyone else is fretting over Citibank

Citi has the biggest name, but a handful of regional banks are expected to be the big winners after the Fed releases its second round of stress test results. Continue reading

Four converted thrifts that are ripe for takeovers in 2015

The banks are set to reach the three-year anniversary of their initial public offerings, making them potential targets amid rampant consolidation in the industry. Continue reading

Three companies benefiting from Obamacare's expanded access to mental health services

The law made access to treatment for addiction and other problems widely available. More patients with the means to pay for care is creating greater opportunities for providers. Continue reading

Meet the journalists

William McConnell

Assistant Managing Editor: Regulatory & Arbitrage

Corinthian Colleges and the history of for-profit education crackdowns

The Nasdaq is delisting shares of for-profit educator Corinthian Colle ... Video

More Regulatory video

The Deal's Webcast Series

If you have not had the chance to enjoy our Webcast Series, now is the time. Join these free 60-minute discussions and get a handle on the latest strategies and tactics in private equity, cross-border and middle market dealmaking and more.

Industry Events

View information on all upcoming industry events which The Deal representatives are participating in.

The Deal Economy Event

The Deal’s senior journalists host the industry's leading M&A forecasting event, an invitation-only gathering of influential members of the deal community discussing the outlook for dealmaking in the coming year.

The Deal on Twitter

Follow @TheDealNewsroom for the latest news across mergers and acquisitions, auctions, financings, restructurings and more!